Source:http://linkedlifedata.com/resource/pubmed/id/12614926
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2003-3-4
|
pubmed:abstractText |
In recent years, an intense interest has developed in the association between Parkinson's disease (PD) and hyperhomocysteinemia. Homocysteine (Hcy) is a neuronal excitotoxic amino acid, and is well known as a risk factor for vascular diseases. Some reports suggest that the administration of L-DOPA may promote hyperhomocysteinemia and idiopathic atherosclerosis. In this study, we report that a mild hypertrophy of the intima-media complex (IMC) of the carotid artery, which has been established as a marker for systemic atherosclerosis, is observed in PD patients compared with normal subjects. PD patients that were treated with L-DOPA for long durations showed a hypertrophic IMC, while the patients that were not treated with L-DOPA did not show any hypertrophic changes in the IMC. These hypertrophic changes were observed primarily in patients with a Hoehn-Yahr stage of 3-5. PD patients with hypertrophic IMC of the carotid artery also exhibited elevated plasma levels of Hcy associated with the C677T genotype of 5,10-methylenetetrahydrofolate reductase (MTHFR). Moreover, a prolonged duration of treatment with L-DOPA in patients with MTHFR T/T genotype enhanced the hypertrophy of IMC, compared with patients with the C/C or C/T genotype. These results suggest that hyperhomocysteinemia promoted by the C677T genotype of MTHFR and prolonged treatment with L-DOPA enhances atherosclerosis in PD patients and affects their general condition.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-510X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
207
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
19-23
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12614926-Aged,
pubmed-meshheading:12614926-Analysis of Variance,
pubmed-meshheading:12614926-Carotid Arteries,
pubmed-meshheading:12614926-Female,
pubmed-meshheading:12614926-Homocysteine,
pubmed-meshheading:12614926-Humans,
pubmed-meshheading:12614926-Hypertrophy,
pubmed-meshheading:12614926-Levodopa,
pubmed-meshheading:12614926-Male,
pubmed-meshheading:12614926-Methylenetetrahydrofolate Reductase (NADPH2),
pubmed-meshheading:12614926-Middle Aged,
pubmed-meshheading:12614926-Oxidoreductases Acting on CH-NH Group Donors,
pubmed-meshheading:12614926-Parkinson Disease,
pubmed-meshheading:12614926-Statistics, Nonparametric,
pubmed-meshheading:12614926-Tunica Intima
|
pubmed:year |
2003
|
pubmed:articleTitle |
Hypertrophy of IMC of carotid artery in Parkinson's disease is associated with L-DOPA, homocysteine, and MTHFR genotype.
|
pubmed:affiliation |
Division of Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Yonago, Japan. kazuhiro@grape.med.tottori-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Comparative Study
|